Neuromodulation Market Access

Founded in 2022, Neuromodulation Market Access was established to support the development and execution of go-to-market strategies for the Medical Technology and Healthcare Innovation industry. Specialising in, but not limited to, devices utilising the science of Neuromodulation, NMA was established as a result of the founders first-hand experience of the difficulties and subsequent successes in commercialising a Class IIa medical device in the UK, Europe, and Rest of the World. NMA are passionate about sharing our experiences to enable a faster and more cost-effective route to the adoption and reimbursement of disruptive Medical Technologies for the benefit of the patients and healthcare systems worldwide. Committed to adding value and real-world experience for our customers who range from start-ups to large MedTech, Neuromodulation Market Access prides itself on it’s professionalism and experience. Born from a passion to improve the health and well-being of patients all over the world.